NASDAQ : SKYE
Skye Bioscience, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.80M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 15.94M | 15.80M | 17.73M | 7.85M | 12.30M | 4.92M |
| Research & Development | 32.11M | 42.36M | 18.70M | 5.82M | 6.01M | 2.93M |
| Other Operating Expenses | -3.00 | |||||
| Operating Expenses | 48.06M | 58.16M | 36.43M | 13.67M | 18.31M | 7.85M |
| Operating Income | -48.06M | -58.16M | -36.43M | -13.67M | -18.31M | -7.85M |
| Interest Expense | -5.50K | -749.31K | -906.27K | -665.13K | -769.16K | |
| Interest & Investment Income | 965.39K | 1.88M | 3.03M | 99.97K | 19.01K | 3.00 |
| Other Non Operating Income (Expenses) | -2.91K | -502.00 | -2.20K | -60.50K | -21.16K | |
| EBT Excluding Unusual Items | -47.10M | -56.28M | -34.15M | -14.48M | -19.02M | -8.64M |
| Gain (Loss) on Sale of Assets | 449.59K | 360.75K | 1.36M | -307.09K | ||
| Asset Writedown | -589.66K | -409.35K | -456.51K | |||
| Legal Settlements | -3.25M | 4.23M | 151.84K | |||
| Other Unusual Items | -1.38M | 117.95K | ||||
| Pretax Income | -50.49M | -55.92M | -26.56M | -37.64M | -19.47M | -8.52M |
| Income Tax Expense | 3.40K | 5.40K | 10.07K | 3.60K | 6.74K | 2.10K |
| Net Income | -50.49M | -55.92M | -26.57M | -37.64M | -19.48M | -8.52M |
| Net Income to Common | -50.49M | -55.92M | -26.57M | -37.64M | -19.48M | -8.52M |
| Shares Outstanding (Basic) | 4.96M | 4.96M | 4.56M | 875.75K | 277.63K | 203.30K |
| Shares Outstanding (Diluted) | 4.96M | 4.96M | 4.56M | 875.75K | 277.63K | 203.30K |
| EPS (Basic) | -10.18 | -11.28 | -5.83 | -42.99 | -70.17 | -41.92 |
| EPS (Diluted) | -10.24 | -11.28 | -5.84 | -42.99 | -70.17 | -41.92 |
| Free Cash Flow | -38.81M | -43.07M | -26.84M | -13.96M | -12.84M | -6.57M |
| Free Cash Flow Per Share | -7.83 | -8.69 | -5.88 | -15.95 | -46.24 | -32.30 |
| EBITDA | -47.37M | -57.44M | -36.13M | -13.55M | -18.20M | -7.81M |
| D&A For EBITDA | 689.39K | 723.35K | 298.64K | 124.25K | 115.00K | 34.13K |
| EBIT | -48.06M | -58.16M | -36.43M | -13.67M | -18.31M | -7.85M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 8.07M | 5.88M | 68.42M | 1.26M | 1.24M | 8.98M |
| Short-Term Investments | 2.00M | 19.85M | 74.12K | |||
| Cash & Short-Term Investments | 10.06M | 25.74M | 68.42M | 1.26M | 1.32M | 8.98M |
| Other Receivables | 7.36K | 10.47K | 5.07K | 698.85K | 179.69K | |
| Receivables | 7.36K | 10.47K | 5.07K | 698.85K | 179.69K | |
| Prepaid Expenses | 415.16K | 504.89K | 201.96K | 194.26K | 780.81K | 567.65K |
| Restricted Cash | 9.08M | 4.58K | 4.57K | |||
| Other Current Assets | 472.23K | 841.56K | 2.20M | 421.08K | 6.66M | 56.87K |
| Total Current Assets | 10.96M | 27.09M | 70.83M | 11.65M | 8.94M | 9.61M |
| Property, Plant & Equipment | 66.60K | 1.17M | 1.88M | 281.26K | 159.04K | 234.68K |
| Other Long-Term Assets | 8.31K | 53.91K | 53.91K | 8.31K | 8.31K | 8.31K |
| Total Assets | 11.03M | 28.31M | 72.76M | 11.94M | 9.11M | 9.86M |
| Accounts Payable | 4.28M | 2.03M | 569.25K | 956.75K | 1.79M | 897.88K |
| Accrued Expenses | 1.66M | 3.91M | 1.77M | 2.06M | 1.12M | 897.33K |
| Short-Term Debt | 143.05K | 4.37M | 55.45K | |||
| Current Portion of Long-Term Debt | 1.85M | 1.97M | ||||
| Current Portion of Leases | 35.70K | 189.65K | 182.43K | 72.04K | 78.70K | 82.37K |
| Other Current Liabilities | 5.42M | 2.07M | 1.82M | 6.44M | 7.22M | 59.73K |
| Total Current Liabilities | 11.53M | 8.21M | 4.34M | 13.90M | 12.12M | 3.91M |
| Long-Term Leases | 84.00K | 273.16K | 171.23K | 78.70K | ||
| Total Liabilities | 11.53M | 8.29M | 4.61M | 14.07M | 12.12M | 3.99M |
| Common Stock | 35.14K | 33.38K | 30.98K | 12.35K | 3.65K | 476.11K |
| Additional Paid-In Capital | 209.64M | 206.87M | 199.07M | 102.24M | 63.73M | 52.64M |
| Retained Earnings | -210.17M | -186.87M | -130.95M | -104.38M | -66.74M | -47.26M |
| Total Common Equity | -497.31K | 20.02M | 68.15M | -2.13M | -3.01M | 5.86M |
| Shareholders' Equity | -497.31K | 20.02M | 68.15M | -2.13M | -3.01M | 5.86M |
| Total Liabilities & Equity | 11.03M | 28.31M | 72.76M | 11.94M | 9.11M | 9.86M |
| Total Debt | 178.75K | 273.65K | 455.59K | 4.62M | 1.98M | 2.14M |
| Net Cash (Debt) | 9.89M | 25.46M | 67.96M | -3.36M | -663.88K | 6.85M |
| Net Cash Per Share | 1.99 | 5.14 | 14.90 | -3.84 | -2.39 | 33.68 |
| Filing Date Shares Outstanding | 4.43M | 4.17M | 3.87M | 3.51M | 485.77K | 247.96K |
| Total Common Shares Outstanding | 4.39M | 4.17M | 3.87M | 1.54M | 456.76K | 238.05K |
| Working Capital | -572.22K | 18.89M | 66.49M | -2.25M | -3.18M | 5.70M |
| Book Value Per Share | -0.11 | 4.80 | 17.60 | -1.38 | -6.59 | 24.63 |
| Tangible Book Value | -497.31K | 20.02M | 68.15M | -2.13M | -3.01M | 5.86M |
| Tangible Book Value Per Share | -0.11 | 4.80 | 17.60 | -1.38 | -6.59 | 24.63 |
| Machinery | 126.89K | 1.65M | 1.64M | 124.76K | ||
| Leasehold Improvements | 13.95K | 23.92K | 23.92K | 13.95K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -50.49M | -55.92M | -26.57M | -37.64M | -19.48M | -8.52M |
| Depreciation & Amortization | 689.39K | 723.35K | 298.64K | 124.25K | 115.00K | 34.13K |
| Other Amortization | 599.01K | 329.89K | 489.60K | 593.80K | ||
| Loss (Gain) From Sale of Assets | 147.69K | -360.75K | -1.35M | 303.01K | ||
| Asset Writedown & Restructuring Costs | 21.22M | |||||
| Stock-Based Compensation | 6.30M | 7.77M | 8.32M | 987.51K | 629.03K | 869.21K |
| Other Operating Activities | 3.25M | -3.91M | 1.20M | 6.27M | -96.79K | |
| Change in Accounts Payable | 1.06M | 1.40M | -586.53K | -701.28K | 799.74K | 518.64K |
| Change in Other Net Operating Assets | 238.26K | 3.34M | -2.04M | 231.98K | -1.56M | 128.31K |
| Operating Cash Flow | -38.81M | -43.06M | -25.24M | -13.95M | -12.74M | -6.47M |
| Capital Expenditures | -6.31K | -1.60M | -12.55K | -94.52K | -90.87K | |
| Sale of Property, Plant & Equipment | 450.44K | 360.75K | 1.36M | 5.53M | ||
| Cash Acquisitions | 1.08M | 5.31M | ||||
| Investment in Securities | 22.75M | -19.85M | ||||
| Investing Cash Flow | 23.20M | -19.50M | -245.62K | 6.60M | 5.21M | -90.87K |
| Short-Term Debt Issued | 4.97M | |||||
| Long-Term Debt Issued | 680.90K | |||||
| Total Debt Issued | 4.97M | 680.90K | ||||
| Long-Term Debt Repaid | -259.33K | -891.66K | ||||
| Net Debt Issued (Repaid) | -178.81K | 4.71M | -210.76K | |||
| Issuance of Common Stock | 90.00M | 12.00M | 1.97K | 14.01M | ||
| Other Financing Activities | 17.69K | 29.57K | -6.43M | -271.08K | -935.26K | |
| Financing Cash Flow | -161.13K | 29.57K | 83.56M | 16.44M | -208.79K | 13.08M |
| Net Cash Flow | -15.77M | -62.53M | 58.08M | 9.09M | -7.74M | 6.51M |
| Free Cash Flow | -38.81M | -43.07M | -26.84M | -13.96M | -12.84M | -6.57M |
| Free Cash Flow Per Share | -7.83 | -8.69 | -5.88 | -15.95 | -46.24 | -32.30 |
| Levered Free Cash Flow | -18.71M | -22.95M | -12.94M | -11.13M | -9.44M | -3.28M |
| Unlevered Free Cash Flow | -18.71M | -22.95M | -13.07M | -10.89M | -9.51M | -3.39M |
| Cash Interest Paid | 5.50K | 433.34K | 198.35K | 333.55K | 44.09K | |
| Cash Income Tax Paid | 3.40K | 5.40K | 5.20K | 3.60K | 6.74K | 1.60K |
| Change in Working Capital | 1.29M | 4.73M | -2.63M | -469.31K | -761.90K | 646.94K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.02M | 24.03M | 85.86M | 33.59M | 14.80M | 24.76M |
| Enterprise Value | -3.86M | -10.96M | 18.64M | 32.89M | 16.97M | 15.65M |
| Last Close Price | 1.28 | 6.00 | 22.64 | 21.76 | 32.40 | 104.00 |
| PB Ratio | 1.20 | 1.26 | -15.76 | -4.92 | 4.22 | |
| P/TBV Ratio | 1.20 | 1.26 | 4.22 | |||
| Debt / Equity Ratio | -0.36 | 0.01 | 0.01 | -2.17 | -0.66 | 0.36 |
| Net Debt / Equity Ratio | 19.88 | -1.27 | -1.00 | -1.58 | -0.22 | -1.17 |
| Net Debt / EBITDA Ratio | 0.21 | 0.44 | 1.88 | -0.25 | -0.04 | 0.88 |
| Net Debt / FCF Ratio | 0.26 | 0.59 | 2.53 | -0.24 | -0.05 | 1.04 |
| Quick Ratio | 0.87 | 3.14 | 15.77 | 0.14 | 0.12 | 2.30 |
| Current Ratio | 0.95 | 3.30 | 16.32 | 0.84 | 0.74 | 2.46 |
| Return on Equity (ROE) | -233.87% | -126.85% | -80.48% | -1,364.20% | -269.91% | |
| Return on Assets (ROA) | -95.06% | -71.93% | -53.76% | -81.18% | -120.69% | -78.31% |
| Return on Capital Employed (ROCE) | 9,663.30% | -289.30% | -53.20% | 697.30% | 608.80% | -132.10% |
| Earnings Yield | -752.93% | -232.69% | -30.94% | -112.07% | -131.64% | -34.42% |
| FCF Yield | -684.80% | -179.20% | -31.26% | -41.57% | -86.75% | -26.52% |
| Buyback Yield / Dilution | -0.08% | -8.71% | -420.79% | -215.43% | -36.56% | -75.70% |